Trending News Today: Former Eli Lilly President Nominated for Health and Human Services Secretary

President Donald Trump recently suggested that Republicans could further reduce taxes for Americans by repealing the Affordable Care Act (ACA) individual mandate, according to The New York Times. Although the ACA was excluded from the tax reform proposal being debated by legislators, Trump tweeted that cutting the “top rate to 35% w/all of the rest going to middle income cuts.” The new suggestion came only hours before the Senate Finance Committee started to debate the tax reform bill, which would cut $1.5 trillion in taxes, according to the article.

Yesterday, Alex M. Azar II, former Eli Lilly executive and a health official for George W. Bush, was nominated by Trump to be the secretary of health and human services, The New York Times reported. If confirmed, Azar would replace Tom Price, MD, who resigned after a scandal involving his use of chartered jets for government travel. The Times said that Azar has significant knowledge of how to advance the GOP’s desire to repeal and replace the ACA, which appeals to the administration.

After the first hepatitis C virus (HCV) cure was approved, San Francisco, CA, developed the End Hep C SF program, which aims to eliminate the virus, according to STAT. Under the program, health workers test patients for HCV and locate homeless individuals who have yet to pick up their medications. Additionally, more physicians are being educated about HCV and patients are able to keep their drugs at a syringe exchange, according to the article. Advocates said that the largest hurdle to overcome is getting individuals into the program.

Stay up to date on the latest news in specialty pharmacy by getting Specialty Pharmacy Times in your mailbox or inbox for free!

Click here to sign up for free for the bi-monthly Specialty Pharmacy Times print journal delivered to your address.

Click here to sign up for our email newsletters delivered every Monday, Wednesday, and Friday, in addition to breaking news alerts.

Click here to follow us on Facebook. 

Click here to follow us on Twitter. 

Click here to join our LinkedIn group. 

Most Popular

Related Articles

The pros and cons of oral oncolytics versus infusion therapy regarding efficacy, safety, and patient adherence.
Top news of the day across the health care landscape.
The specialty drug market saw a 16% growth rate in 2018.
Company Profile >
Contributors >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Contact Us
Terms & Conditions
MJH Associates >
Pharmacy Times
American Journal of Managed Care
MD Magazine
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2018
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.